2. Gene
  3. Cs - citrate synthase Gene

Cs - citrate synthase Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Rattus norvegicus

基因 ID: 170587 | 基因类型: protein coding

关于 Cs

功能概要

Enables citrate (Si)-synthase activity. Involved in acetyl-CoA metabolic process; carboxylic acid metabolic process; and tricarboxylic acid cycle. Located in mitochondrion. Orthologous to human CS (citrate synthase). [provided by Alliance of Genome Resources, Apr 2022]

Cs 基因产物(1)

mRNA Protein Name
NM_130755.1 NP_570111.1 citrate synthase, mitochondrial precursor
基因本体论
  • 分子功能
  • 生物过程
  • 细胞组分
分子功能 GO 注释 逻辑证据 参考文献 来源
enables citrate (Si)-synthase activity IDA
IDA: 通过直接分析推断
818082 RGD
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in acetyl-CoA metabolic process IDA
IDA: 通过直接分析推断
818082 RGD
involved in citrate metabolic process IDA
IDA: 通过直接分析推断
818082 RGD
involved in heart development IEP
IEP: 通过表达模式推断
14984324 RGD
involved in oxaloacetate metabolic process IDA
IDA: 通过直接分析推断
818082 RGD
involved in tricarboxylic acid cycle IDA
IDA: 通过直接分析推断
9712727 RGD
细胞组分 GO 注释 逻辑证据 参考文献 来源
located in mitochondrion IDA
IDA: 通过直接分析推断
15809022 RGD
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

citrate synthase, mitochondrial

citrate (Si)-synthase

相关产品

Approval
生物活性分子 (12)
目录号 产品名 作用方式
纯度 是否罕见病
HY-50935 Troglitazone 99.78% 否
HY-109015 Tucidinostat Inhibitor 98.74% 否
HY-B0165A Pravastatin sodium 99.38% 是
HY-16276 Osilodrostat Inhibitor 99.90% 是
HY-17005 Olmesartan medoxomil Inhibitor 98.95% 否
HY-B0023 Azelnidipine Inhibitor 99.79% 否
HY-100471 Esaxerenone Antagonist 99.93% 否
HY-16276A Osilodrostat phosphate Inhibitor 98.83% 是
HY-N7101 Cefpodoxime Proxetil Inhibitor 98.93% 否
HY-14818A Laninamivir octanoate Inhibitor 98.57% 否
HY-B1595 Cefmetazole Inhibitor 99.84% 否
HY-B0165 Pravastatin / 否
Clinical Phase
生物活性分子 (15)
目录号 产品名 作用方式
纯度 Phase
HY-100401 Pactimibe Inhibitor 99.98% Phase 3
HY-16445 Sapacitabine Chemical 98.69% Phase 3
HY-124526 Chiauranib Inhibitor 98.97% Phase 3
HY-100401A Pactimibe sulfate Inhibitor 98.0% Phase 3
HY-141511 Coppersensor 1 ≥98.0% Phase 2
HY-160929 Linafexor Agonist 99.58% Phase 2
HY-14792B Inolitazone dihydrochloride Agonist 98.45% Phase 2
HY-14783 Apricoxib Inhibitor 98.84% Phase 2
HY-106888A CS-722 / Phase 2
HY-137005 CS1 / Phase 2
HY-14792 Inolitazone Agonist / Phase 2
HY-P6306A CS-6253 TFA 98.53% Phase 1
HY-145995 CS12192 Inhibitor / Phase 1
HY-14976 CS-0777 Modulator / Phase 1
HY-19404 Embeconazole Inhibitor / Phase 1
抗体抑制剂 (2)
目录号 产品名 作用方式
纯度 Phase
HY-P99758 Nofazinlimab Inhibitor 98.83% Phase 3
HY-P99270 Tigatuzumab Inducer 98.18% Phase 2
Pre-clinical Phase
生物活性分子 (78)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-B1692 L-Methionine-DL-sulfoximine Inhibitor ≥98.0% 否
HY-P6306 CS-6253 98.84% 否
HY-148907 CS640 Inhibitor 96.13% 否
HY-148913 CS587 Inhibitor 98.18% 否
HY-B0165AR Pravastatin sodium (Standard) 98.10% 否
HY-P2727 Chondroitinase ABC / 否
HY-P3522 REDV 99.33% 否
HY-124704 Chst15-IN-1 Inhibitor 98.01% 否
HY-W753658 Coppersensor-3 97.0% 否
HY-121447 Heneicosanoic acid 98.0% 否
HY-130086 Bis-​PEG4-​NHS ester 97.0% 否
HY-132996 4-Isothiocyanatophenyl α-D-Mannopyranoside 99.87% 否
HY-150611 EGFR-IN-70 Inhibitor 98.12% 否
HY-14955 Managlinat dialanetil Inhibitor 99.67% 否
HY-116228 Cadrofloxacin Inhibitor 98.21% 否
HY-14180 PHA 408 Inhibitor 99.40% 否
HY-P3522A REDV TFA 99.81% 否
HY-108493 CS-2100 Agonist 99.12% 否
HY-15801 HG-14-10-04 Inhibitor 99.09% 否
HY-D0798 Catechol violet 90.0% 否
HY-P10948A CS-VIP 8 hydrochloride Inhibitor 96.04% 否
HY-105268 AzddMeC Inhibitor 98.96% 否
HY-106174 Lapisteride Inhibitor 99.0% 否
HY-106850 3′-Azido-2′,3′-dideoxyuridine Inhibitor 99.59% 否
HY-109015S Tucidinostat-d4 Inhibitor 98.63% 否
HY-111640 3'-Azido-3'-deoxy-5-methylcytidine Inhibitor 99.90% 否
HY-17005R Olmesartan medoxomil (Standard) Inhibitor 99.35% 否
HY-50935S Troglitazone-d4 98.19% 否
HY-169481 AP-1 Degrader 97.8% 否
HY-B0165CS Pravastatin-d3 sodium salt 99.02% 否
HY-Q51222 ZINC110492 Ligand 90.0% 否
HY-100413 CS-526 Antagonist / 否
HY-105114A Imitrodast sodium Inhibitor / 否
HY-106789 Plaunotol / 否
HY-106888 CS-722 Free base / 否
HY-123022 Tomopenem Inhibitor / 否
HY-133606 3,4,5-Trichlorosyringol / 否
HY-143445 EGFR-IN-48 Inhibitor / 否
HY-14792C Inolitazone hydrochloride hydrate Agonist / 否
HY-14818C Laninamivir octanoate hydrate / 否
HY-148863 Cavα2δ1&NET-IN-2 Inhibitor / 否
HY-14977 CS-0777-P Agonist / 否
HY-15115 SUAM 1221 Inhibitor / 否
HY-159936 CS4 / 否
HY-163752 CS17919 Inhibitor / 否
HY-169247 Pam2CS-DMAPA / 否
HY-169427 FRF-06-057 Inhibitor / 否
HY-169982 EGFR-IN-136 Inhibitor / 否
HY-17005S Olmesartan medoxomil-d6 Inhibitor / 否
HY-171958 PROTAC EGFR degrader 12 Degrader / 否
HY-173132 AKR1Cs-IN-1 Inhibitor / 否
HY-175806 CS47 / 否
HY-178242 PROTAC EGFR degrader 16 Degrader / 否
HY-179238 CS-1-103 Inhibitor / 否
HY-19633 CS-003 Free base Antagonist / 否
HY-19633A CS-003 / 否
HY-B0023S Azelnidipine-d7 Inhibitor / 否
HY-B0165AS Pravastatin-13C,d3 sodium / 否
HY-B0165S Pravastatin-d9 sodium / 否
HY-D3202 Lyso-CS2 / 否
HY-N7101S Cefpodoxime proxetil-d7 / 否
HY-P10797 TAT-N24 Inhibitor / 否
HY-P10948 CS-VIP 8 Inhibitor / 否
HY-P1816 Fibronectin CS1 Peptide / 否
HY-P4021 Mca-KKEDVV-Abu-CS-Abu-S-(NO2)F-KK-NH2 / 否
HY-RS03221 CS Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-107163 CS 461 Inhibitor / 否
HY-138024 Tacapenem Inhibitor / 否
HY-14955A (Rac)-Managlinat dialanetil / 否
HY-174532 Human TGFB3 mRNA / 否
HY-175198 Cs-2d Inhibitor / 否
HY-175489 D-CS319 Inhibitor / 否
HY-178019 NDM-1-IN-10 Inhibitor / 否
HY-D0248 Acid Blue 45 / 否
HY-N7101S1 Cefpodoxime Proxetil-d6 Inhibitor / 否
HY-RS16750 Cs Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23189 Cs Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-U00211 CS476 Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Cs NCBI NCBI:1431
Canis familiaris Cs NCBI NCBI:474403
Macaca fascicularis Cs NCBI NCBI:101926620
Mus musculus Cs NCBI NCBI:12974
Susscrofa domestica Cs NCBI
Macaca mulatta Cs NCBI NCBI:709604
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z